Despite the promising nature of his research, Dr. Roy faces several challenges in bringing the bioartificial kidney to market. These include ensuring biocompatibility, preventing immune rejection, and achieving long-term functionality. Additionally, the device must undergo rigorous clinical trials to demonstrate its safety and efficacy before receiving regulatory approval for widespread use.
